Cosmic Crypto ClubCosmic Crypto Club
Home
Markets
Tools
Academy
Brokers
DiscordLaunch Hub
Cosmic Crypto Club

Free trading education, market data & a community of serious traders. Join thousands learning to trade Crypto, Forex & Stocks.

Markets

  • Market Overview
  • Cryptocurrencies
  • Stocks
  • Forex
  • Indices
  • Commodities
  • News

Tools & Software

  • All Tools
  • Calculators
  • Screener
  • Economic Calendar
  • Trading Journal
  • Trading Software

Academy

  • Academy Home
  • Strategies
  • Glossary
  • How-To Guides
  • DeFi Protocols
  • Tax Guides

Brokers & Company

  • All Brokers
  • Crypto Exchanges
  • Prop Firms
  • About Us
  • Contact
  • FAQ

© 2026 Cosmic Crypto Club. All rights reserved.

Terms of ServicePrivacy PolicyCookie PolicyAffiliate DisclosureRisk & Investment Disclaimer

The information on cosmiccrypto.club is provided for general information purposes only. It does not constitute legal, financial, or professional advice. Cosmiccrypto.club does not accept responsibility for any loss or damage arising from reliance on the site's content. Users should seek independent advice and information before making financial decisions. Trading cryptocurrencies, stocks, and other financial instruments involves substantial risk and may not be suitable for every investor.

Back to Stocks
GTBP
Rank #1986GTBP

GT Biopharma, Inc.

$0.46

-6.61% (Daily)

Market Cap

$12.16M

Revenue

$N/A

Rank by MCap

#1986

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Michael Martin Breen L.L.B.

Headquarters

San Francisco, CA

Employees

1

About GT Biopharma, Inc.

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 that targets B7-H3 on the surface of ad...

GT Biopharma, Inc. Price Chart

Loading chart…

Community & Socials

Website

Explore Related

Browse ETFsExplore CryptocurrencyView All S&P 500 Stocks